Antiepileptic drugs during pregnancy: pharmacokinetics and transplacental transfer.

Marco De Santis, Carmen De Luca, Ilenia Mappa, Elena Cesari, Terryann Spagnuolo, Daniela Visconti, Alessandro Caruso, Tomasella Quattrocchi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

11 Citazioni (Scopus)

Abstract

Epilepsy represents the most common maternal neurological disorder requiring continuous treatment during pregnancy. Maintaining optimum seizure control is an important objective in pregnancy, and the majority of women with epilepsy will need to continue antiepileptic drugs (AEDs). AEDs are frequently used to treat several other conditions, such as headaches and mood disorders. They have been associated with an increased risk of congenital malformations, minor anomalies, congenital syndrome and development disorders. This risk seems to be higher among women using polypharmacy and valproic acid. Neural tube defects are associated with valproic acid and carbamazepine exposure. New AEDs seem to have a less teratogenic effect, but human experience is still limited. The purpose of this review is to provide an update on AED exposure in pregnancy, focusing on pharmacokinetics and transplacental transport.
Lingua originaleEnglish
pagine (da-a)781-788
Numero di pagine8
RivistaCurrent Pharmaceutical Biotechnology
Stato di pubblicazionePubblicato - 2011

Keywords

  • antiepileptic drugs
  • placenta
  • pregnancy
  • teratology

Fingerprint Entra nei temi di ricerca di 'Antiepileptic drugs during pregnancy: pharmacokinetics and transplacental transfer.'. Insieme formano una fingerprint unica.

Cita questo